Extensive genomic analysis led by MD Anderson researchers has opened new avenues to explore in the treatment of a rare and tenaciously lethal type of liver cancer.
Cholangiocarcinoma — cancer of the bile ducts — is treated with chemotherapy and surgery. It’s occurring more frequently in the United States, with incidence rising from .44 cases per 100,000 population in 1973 to 1.18 per 100,000 in 2012. Median survival of patients...